Lupus Sci Med 2016
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus.
Related Questions
New comment by at Arthritis Clinic of Central Texas ( July 30, 2022)
Agree on all above between sleep, OSA, heart, lung disease and vitamins. These are routine checks for us when we evaluate fatigue in SLE.
Exercise plays a paradoxic role in t...
I get a lot of low false positive ds dna (sometimes high- 300) in quest and labcorp but their crithidia specific dsDNA labs when repeated are ne...
New answer by at Uniformed Services University of the Health Sciences (USUHS) (April 13, 2023)
What a great question with many facets. The information I provide is meant to be very practical. These answers are from the viewpoint of a rheumatologist and not an immunologi...